Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 11, 2026 09:00 ET | Source: Eleos Health

CalMHSA Selects Eleos as Statewide AI Technology Partner for Behavioral Health

BOSTON and OAK BROOK, Ill. and SACRAMENTO, Calif., Feb. 11, 2026 (GLOBE NEWSWIRE) -- After rigorous deliberation, Eleos, the leader in AI for behavioral health, today announced that the California...
February 11, 2026 03:30 ET | Source: Custom Market Insights

[Latest] Global Cell Therapy Raw Materials Market Size/Share Worth USD 29.3 Billion by 2035 at a 18.9% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Austin, TX, USA, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Cell Therapy Raw Materials Market Size, Trends and Insights By Product (Media,...
February 11, 2026 02:00 ET | Source: Reset Health

Reset Health Further Strengthens Advisory Board With Appointment of Pinder Sahota

LONDON, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Reset Health (“the Company”), the experts in the personalised management of chronic disease, today announces Pinder Sahota has joined the Company as a...
January 30, 2026 07:00 ET | Source: Nutriband Inc.

Nutriband Inc. provides summary of Annual Shareholder Meeting Key Discussion Points

Annual shareholder meeting highlights
January 28, 2026 07:40 ET | Source: OKYO Pharma LTD

OKYO Pharma Announces Successful Type C Meeting with the FDA

LONDON and NEW YORK, Jan. 28, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of...
January 08, 2026 08:30 ET | Source: PharmAla Biotech

PharmAla To Supply Østfold Hospital Trust with LaNeo™ MDMA for Clinical Research

PharmAla inks contract with Ostfold Hospital Trust in Oslo to supply clinical trial in exchange for both cash and a data license
January 08, 2026 08:00 ET | Source: ProQR Therapeutics N.V.

ProQR Announces Encouraging AX-0810 Phase 1 Safety and PK Data, Development Candidate Selections, and 2026 Outlook

Initial AX-0810 data show no safety signals after 4 weeks of dosing and pharmacokinetics consistent with non-clinical data; Phase 1 enrollment and dosing in healthy volunteers ongoing with target...
January 07, 2026 08:00 ET | Source: Science 37, Inc.

Science 37 Named Finalist in Two Categories for the 2026 SCOPE Awards

Science 37 Named Finalist for 2026 SCOPE Participant Engagement and Site Innovation Awards.
December 18, 2025 08:00 ET | Source: Nutriband Inc.

Nutriband Inc. Signs Letter of Intent with Qvanta Group of Companies to Explore Advanced Technology Solutions for Abuse-Deterrent Pharmaceutical Innovation Strategic Exploration

Quanta LOI
December 18, 2025 07:00 ET | Source: Nutriband Inc.

Nutriband Differentiates Prescription Fentanyl from Illicit Fentanyl in Response to United States Executive Order Designating Fentanyl as a Weapon of Mass Destruction

Fentanyl designation Response